Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

1Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee. Search for other works by this author on: 2Department of Computational Biology, St. Jude Children’s Research ...

The StrataQuest software was coupled with TissueFAXS, offering a convenient workflow that could automatically acquire up to ...

Chi Hoon Park, have successfully generated CAR-M (Chimeric Antigen Receptor Macrophages) by stably inserting synthetic genes into human macrophages derived from peripheral blood using a lentiviral ...

kuleuven.be Intestinal resident macrophages are at the front line of host defence at the mucosal barrier within the gastrointestinal tract and have long been known to play a crucial role in the ...

Macrophages are ubiquitous innate immune cells found in almost every organ of the body. This family of phagocytes, represented by a variety of different subtypes, performs tissue-specific functions as ...